MEGAN TUCKER: Open Payments
NPI 1730401647 · SCOTTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,389 in 112 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,577 · 2025 $2,389
Food & beverage: $2,310Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $415 |
| Vanda Pharmaceuticals Inc. | 11 | $357 |
| Janssen Pharmaceuticals, Inc | 17 | $328 |
| Axsome Therapeutics, Inc. | 12 | $310 |
| Teva Pharmaceuticals USA, Inc. | 13 | $278 |
| Otsuka America Pharmaceutical, Inc. | 14 | $255 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $99 |
| Alkermes, Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Biogen, Inc. | 2 | $43 |
Products named: VRAYLAR, Auvelity, FANAPT, SPRAVATO, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
